undefined undefined
NaN.000
NaN.00%
This whale alert can help traders discover the next big trading opportunities. ...
今天 01:35
Stephens started coverage of Blueprint Medicines (NASDAQ:BPMC) with a buy rating and a place on its best idea list. The investment firm said it views the company’s Ayvakit franchise as “an up-and-comi...
05-15 01:35
CAMBRIDGE, Mass., May 6, 2024 /PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective May 1, 2024, the Compensation Committee of Blueprint Medicines' ...
05-07 04:01
HC Wainwright & Co.:维持Blueprint Medicines(BPMC.US)评级,由买入调整至买入评级, 目标价由125.00美...
05-04 04:20
2024 Financial Guidance Blueprint Medicines now anticipates approximately $390 million to $410 million in global AYVAKIT net product revenues for all approved indications in 2024, an increase
05-02 19:04
Blueprint Medicines (NASDAQ:BPMC) has been analyzed by 7 analysts in the last t...
04-26 20:00
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
04-26 18:20
Needham analyst Ami Fadia reiterates Blueprint Medicines (NASDAQ:BPMC) with a Buy and maintains $97 price target.
04-26 17:35
During the last three months, 6 analysts shared their evaluations of Blueprint ...
04-11 03:00
Blueprint Medicines's (NYSE:BPMC) short percent of float has risen 5.37% since ...
02-21 04:45